Background And Aims: We sought to develop a minimally-invasive, robust, accessible nonendoscopic strategy to diagnose Barrett's esophagus (BE), esophageal adenocarcinoma (EAC), and its immediate precursor lesion, high-grade dysplasia (HGD) based on methylated DNA biomarkers applied to a retrievable sponge-capsule device in a cohort representative of the BE population (i.e., mostly short-segment, non-dysplastic BE, NDBE).
View Article and Find Full Text PDFEsopredict is a prognostic assay that risk-stratifies Barrett's esophagus patients to predict future progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC). Established based on foundational studies at Johns Hopkins University, a risk algorithm was developed and clinically validated in two independent studies ( = 320). Esopredict is currently offered as a clinical test under the Clinical Laboratory Improvement Amendments (CLIA) guidelines.
View Article and Find Full Text PDFresistance has been an important trait in potato () breeding for decades. Our aim was to complement phenotypic testing with genetic marker analysis. We analysed the results of resistance greenhouse testing in 4601 tubers of 2918 breeding clones from 11 years.
View Article and Find Full Text PDFIntroduction: Comprehensive local data on adolescent health are often lacking, particularly in lower resource settings. Furthermore, there are knowledge gaps around which interventions are effective to support healthy behaviours. This study generates health information for students from cities in four middle-income countries to plan, implement and subsequently evaluate a package of interventions to improve health outcomes.
View Article and Find Full Text PDF